2.5 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML Injection [Opdivo Qvantig]
RxNorm concept 2728492, branded drug (sbd). Prescribable name: OPDIVO Qvantig 300 MG / 5,000 UNT in 2.5 ML Injection.
- RxCUI
- 2728492
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2728492 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Opdivo Qvantig (nivolumab-hyaluronidase-nvhy 300 MG / 5,000 UNT) per 2.5 ML Injection
Related concepts
- hyaluronidase-nvhy 2000 UNT/ML (SCDC, consists of)
- nivolumab-nvhy 120 MG/ML (SCDC, consists of)
- hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML [Opdivo Qvantig] (SBDC, consists of)
- Injection (DF, has dose form)
- Opdivo Qvantig (BN, has ingredient)
- 2.5 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2728492 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2728492 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2728492. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.